Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Driving Petroleum Research Forward with a Syrris CRS
Thursday, March 20, 2014
Collaboration with KISR to manufacture custom reactor system.

Compact Solution for Parallel Blending / Formulation Experiments
Wednesday, March 19, 2014
Asynt’s Vortex Blend offers scientists an efficient, space saving way of performing experiments in parallel.

Mettler Toledo Announces New InMotion AutoSamplers
Friday, March 14, 2014
New flexible and efficient analytical instrument automation offers maximum productivity for laboratories.

Ruggedized Flowmeter for Metering Low Flow Fluids at High Pressure
Wednesday, March 12, 2014
New ruggedized IP67 / NEMA 4 compliant version of OG2 flowmeter from Titan.

Dolomite Introduces Microfluidic System
Friday, February 28, 2014
Dolomite’s Telos system for high throughput droplet microfluidics.

The Future of Photochemistry with Vapourtec’s UV-150
Friday, February 28, 2014
Designed to complement Company’s existing R-Series and E-Series systems.

Precise Low Temperature Control Improves Reaction Reproducibility
Friday, February 28, 2014
DrySyn SnowStorm system from Asynt perform low temperature reactions.

Tornado Hits Chinese Labs
Saturday, February 22, 2014
Offers controlled parallel heating and mechanical stirring.

Temperature Control Hoses with Improved Flow Characteristics
Friday, February 21, 2014
Hoses with smooth internal wall for shorter heating and cooling times.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 921
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv